Clinical

Dataset Information

0

An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer

ABSTRACT: This observational study is a follow-up study of protocol ML18280. Survival data of patients who took part in and concluded study ML18280 will be collected for up to 5 years after LPLV of ML18270.

DISEASE(S): Rectal Neoplasms,Colorectal Cancer

PROVIDER: 2105609 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Transcriptomics Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer
2017-07-27 | GSE101920 | GEO
Unknown Placement of pelvic mesh prior to pelvic radiotherapy using FlexDex™ - a video vignette.
| S-EPMC7818471 | biostudies-literature
Unknown Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma: A Propensity-Matched Analysis.
| S-EPMC8380802 | biostudies-literature
Unknown Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer.
| S-EPMC6167820 | biostudies-literature
Unknown Tumor size in the management of preoperative radiotherapy for locally advanced rectal cancer.
| S-EPMC12480291 | biostudies-literature
Unknown Concurrent nimotuzumab and intensity-modulated radiotherapy for elderly patients with locally advanced nasopharyngeal carcinoma.
| S-EPMC11309944 | biostudies-literature
Unknown Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized Study.
| S-EPMC9104815 | biostudies-literature
Unknown Prognosis and value of preoperative radiotherapy in locally advanced rectal signet-ring cell carcinoma.
| S-EPMC5366911 | biostudies-literature
Unknown Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy.
| S-EPMC10982056 | biostudies-literature
Unknown Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer.
| S-EPMC4342871 | biostudies-literature